Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has sold an aggregate of 21,607,878 shares of the ...

Our country did not cede the nuclear race to the Soviet Union, and we cannot cede the biotechnology race to China now.

Shares of Sana Biotechnology declined after the company said it sold shares of its common stock through its at-the-market facility for $69 million in net proceeds. The stock ticked down 2.6% to $3.06 ...

PDS Biotechnology (NASDAQ:PDSB) reported first-quarter financial results on Wednesday. The transcript from the company's ...

Biocamp 2026, aimed at finalizing Bangladesh’s team for the upcoming International Biology Olympiad (IBO) and providing ...

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has sold an ...

A unicorn is a privately held, venture-backed startup with a reported valuation of $1 billion or more. Coined in 2013, the ...

This biotech firm develops immunotherapies for cancer and autoimmune diseases, with several candidates advancing through ...

Researchers have identified the SHP protein as a key regulator that suppresses cartilage-degrading enzymes and slows osteoarthritis progression.

LIXTE Biotechnology Holdings, Inc. ('LIXTE” or the 'Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech ...

Healthcare Investors lagged its benchmark as biotech faced regulatory hurdles and market rotation. Read the full analysis for ...

The CEO of Caszyme, a biotech company in Vilnius, Lithuania, presented details of Cas12l, a novel compact Cas nuclease with a ...